These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6821852

  • 1. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma.
    Rougier P, Calmettes C, Laplanche A, Travagli JP, Lefevre M, Parmentier C, Milhaud G, Tubiana M.
    Cancer; 1983 Mar 01; 51(5):855-62. PubMed ID: 6821852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K, Michałek K, Majewski P.
    Wiad Lek; 2002 Mar 01; 55(7-8):394-403. PubMed ID: 12428567
    [Abstract] [Full Text] [Related]

  • 10. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J, Campion L, Kraeber-Bodéré F, Chatal JF, GTE Study Group.
    J Clin Endocrinol Metab; 2005 Nov 01; 90(11):6077-84. PubMed ID: 16091497
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff.
    Romero-Lluch AR, Cuenca-Cuenca JI, Guerrero-Vázquez R, Martínez-Ortega AJ, Tirado-Hospital JL, Borrego-Dorado I, Navarro-González E.
    Eur J Nucl Med Mol Imaging; 2017 Nov 01; 44(12):2004-2013. PubMed ID: 28646462
    [Abstract] [Full Text] [Related]

  • 12. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L, Zhou X, Lu J, Wang Y, Xie X, Zhang J.
    J Clin Lab Anal; 2020 Jul 01; 34(7):e23278. PubMed ID: 32141647
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
    Elisei R, Lorusso L, Piaggi P, Torregrossa L, Pellegrini G, Molinaro E, Agate L, Bottici V, Pani F, Cacciato Insilla A, Casella F, Ciampi R, Tognetti I, Materazzi G, Basolo F, Romei C.
    Eur J Endocrinol; 2015 Sep 01; 173(3):297-304. PubMed ID: 26034076
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
    Woliński K, Kaznowski J, Klimowicz A, Maciejewski A, Łapińska-Cwojdzińska D, Gurgul E, Car AD, Fichna M, Gut P, Gryczyńska M, Ruchała M.
    Endokrynol Pol; 2017 Sep 01; 68(4):434-437. PubMed ID: 28585679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Somatostatin in medullary thyroid cancer. In vitro and in vivo studies.
    Pacini F, Elisei R, Anelli S, Basolo F, Cola A, Pinchera A.
    Cancer; 1989 Mar 15; 63(6):1189-95. PubMed ID: 2563668
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
    Saad MF, Fritsche HA, Samaan NA.
    J Clin Endocrinol Metab; 1984 May 15; 58(5):889-94. PubMed ID: 6707192
    [Abstract] [Full Text] [Related]

  • 20. Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
    Kauhanen S, Schalin-Jäntti C, Seppänen M, Kajander S, Virtanen S, Schildt J, Lisinen I, Ahonen A, Heiskanen I, Väisänen M, Arola J, Korsoff P, Ebeling T, Sane T, Minn H, Välimäki MJ, Nuutila P.
    J Nucl Med; 2011 Dec 15; 52(12):1855-63. PubMed ID: 22052128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.